Login

People. Progressive. Principled

Pharma-Website_Banner-Images_B2LR

Citations

Services

Human Research

  1. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing, Gillian Ellison, Shuwen Huang, Hedley Carr, Andrew Wallace, Miika Ahdesmaki, Sanjeev Bhaskar, John Mills BMC Clinical Pathology 2015, 15:5 (24 March 2015)
  2. Prenatal diagnosis of a trisomy 7/trisomy 13 mosaicism, Karin Huijsdens-van Amsterdam, Daniela QCM Barge-Schaapveld, Inge B Mathijssen, Mariëlle Alders, Eva Pajkrt, Alida C Knegt Molecular Cytogenetics 2012, 5:8 (27 January 2012)
  3. A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival, Shahzia Anjum, Evangelia-Ourania Fourkala, Michal Zikan, Andrew Wong, Aleksandra Gentry-Maharaj, Allison Jones, Rebecca Hardy, David Cibula, Diana Kuh, Ian J Jacobs, Andrew E Teschendorff, Usha Menon, Martin Widschwendter Genome Medicine 2014, 6:47 (27 June 2014)
  4. Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case–control study, Rebecca Gilbert, David M. Evans, Freddie C. Hamdy, Mark Lathrop, Carolina Bonilla, William D. Fraser, David E. Neal, Richard M. Martin, Chris Metcalfe, John P. Kemp, J. Athene Lane, Sarah Lewis, Jenny L. Donovan, George Davey Smith Cancer Causes Control 2015, 26:205 (9 December 2014)

Non-human Research

  1. The utility of low-density genotyping for imputation in the Thoroughbred horse, Laura J Corbin1, Andreas Kranis2, Sarah C Blott3, June E Swinburne3, Mark Vaudin3, Stephen C Bishop1 and John A Woolliams1* (4 February 2014)
  2. Genomic signatures of local directional selection in a high gene flow marine organism; the Atlantic cod (Gadus morhua), Einar E Nielsen, Jakob Hemmer-Hansen, Nina A Poulsen, Volker Loeschcke, Thomas Moen, Torild Johansen, Christian Mittelholzer, Geir-Lasse Taranger, Rob Ogden, Gary R Carvalho BMC Evolutionary Biology 2009, 9:276 (1 December 2009)

Nucleon Chemistry/Kits

  1. G6PD gene variants and its association with malaria in a Sri Lankan population, Rajika L Dewasurendra, Kirk A Rockett, S Fernando, Richard Carter, Dominic P Kwiatkowski, Nadira D Karunaweera, in collaboration with the MalariaGEN Consortium Malaria Journal 2015, 14:93 (22 February 2015)
  2. A novel mutation in TTC8 is associated with progressive retinal atrophy in the golden retriever, Louise M Downs, Berit Wallin-Håkansson, Tomas Bergström, Cathryn S Mellersh Canine Genetics and Epidemiology 2014, 1:4 (16 April 2014)
  3. Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution, Ramatoulie E Janha, Archibald Worwui, Kenneth J Linton, Seif O Shaheen, Fatoumatta Sisay-Joof, Robert T Walton BMC Evolutionary Biology 2014, 14:71 (1 April 2014)
  4. Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health Study, Shona M Kerr, Archie Campbell, Lee Murphy, Caroline Hayward, Cathy Jackson, Louise V Wain, Martin D Tobin, Anna Dominiczak, Andrew Morris, Blair H Smith, David J Porteous BMC Medical Genetics 2013, 14:38 (22 March 2013)
  5. Genetic polymorphisms associated with anti-malarial antibody levels in a low and unstable malaria transmission area in southern Sri Lanka, Rajika L Dewasurendra, Prapat Suriyaphol, Sumadhya D Fernando, Richard Carter, Kirk Rockett, Patrick Corran, Dominic Kwiatkowski, Nadira D Karunaweera, in collaboration with the 7 MalariaGEN Consortium Malaria Journal 2012, 11:281 (20 August 2012)
  6. Genome-wide mRNA sequencing of a single canine cerebellar cortical degeneration case leads to the identification of a disease associated SPTBN2 mutation, Oliver P Forman, Luisa De Risio, Jennifer Stewart, Cathryn S Mellersh, Elsa Beltran BMC Genetics 2012, 13:55 (10 July 2012)
  7. Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania, Alphaxard Manjurano, Lucy Okell, Tedson Lukindo, Hugh Reyburn, Raimos Olomi, Cally Roper, Taane G Clark, Sarah Joseph, Eleanor M Riley, Chris Drakeley Malaria Journal 2011, 10:370 (16 December 2011)
  8. Investigation of an outbreak of mycobacteriosis in pigs, Angelika Agdestein, Tone B Johansen, Vladimir Polaček, Bjørn Lium, Gudmund Holstad, Dejan Vidanović, Sanja Aleksić-Kovačević, Anne Jørgensen, Jonas Žultauskas, Sigrun F Nilsen, Berit Djønne BMC Veterinary Research 2011, 7:63 (21 October 2011)
  9. Generation Scotland: Donor DNA Databank; A control DNA resource, Shona M Kerr, David CM Liewald, Archie Campbell, Kerrie Taylor, Sarah H Wild, David Newby, Marc Turner, David J Porteous BMC Medical Genetics 2010, 11:166 (23 November 2010)
  10. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies, Amparo Tolosa, Julio Sanjuán, Adam M Dagnall, María D Moltó, Neus Herrero, Rosa de Frutos BMC Medical Genetics 2010, 11:114 (22 July 2010)
  11. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry, Inês Sousa, Taane G Clark, Richard Holt, Alistair T Pagnamenta, Erik J Mulder, Ruud B Minderaa, Anthony J Bailey, Agatino Battaglia, Sabine M Klauck, Fritz Poustka, Anthony P Monaco, International Molecular Genetic Study of Autism Consortium (IMGSAC) Molecular Autism 2010, 1:7 (25 March 2010)
  12. Comparative assessment of methods for estimating individual genome-wide homozygosity-by-descent from human genomic data, Ozren Polašek, Caroline Hayward, Celine Bellenguez, Veronique Vitart, Ivana Kolčić, Ruth McQuillan, Vanja Saftić, Ulf Gyllensten, James F Wilson, Igor Rudan, Alan F Wright, Harry Campbell, Anne-Louise Leutenegger BMC Genomics 2010, 11:139 (25 February 2010)
  13. Genetic determinants of hair and eye colours in the Scottish and Danish populations, Jonas Mengel-From, Terence H Wong, Niels Morling, Jonathan L Rees, Ian J Jackson BMC Genetics 2009, 10:88 (30 December 2009)
  14. Glucose-6-phosphate dehydrogenase (G6PD) mutations and haemoglobinuria syndrome in the Vietnamese population, Nguyen Hue, Jean Charlieu, Tran Chau, Nick Day, Jeremy J Farrar, Tran Hien, Sarah J Dunstan Malaria Journal 2009, 8:152 (10 July 2009)
  15. The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency, Alice M Wood, Matthew J Simmonds, Darren L Bayley, Paul R Newby, Stephen C Gough, Robert A Stockley Respiratory Research 2008, 9:52 (11 July 2008)
  16. Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis, Alice Brockington, Beatrijs Wokke, Hannah Nixon, Judith Hartley, Pamela J Shaw BMC Medical Genetics 2007, 8:23 (24 April 2007)
  17. Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case–control study, Tobias O Apinjoh, Judith K Anchang-Kimbi, Clarisse Njua-Yafi, André N Ngwai, Regina N Mugri, Taane G Clark, Kirk A Rockett, Dominic P Kwiatkowski, Eric A Achidi, in collaboration with The MalariaGEN Consortium Malaria Journal 2014, 13:236 (16 June 2014)
  18. A genome-wide association study demonstrates significant genetic variation for fracture risk in Thoroughbred racehorses, Sarah C Blott, June E Swinburne, Charlene Sibbons, Laura Y Fox-Clipsham, Maud Helwegen, Lynn Hillyer, Tim DH Parkin, J Newton, Mark Vaudin BMC Genomics 2014, 15:147 (21 February 2014)
  19. Clinical and Molecular Characteristics of Childhood-Onset Stargardt Disease, Fujinami, Kaoru, et al., Ophthalmology (2014).

Invader Chemistry

 

  1. A clinical PCR fragment analysis assay for TA repeat sizing in the UGT1A1 promoter region. Abou Tayoun AN, de Abreu FB, Lefferts JA, Tsongalis GJ. Clin Chim Acta. 2013 Jun 25;422:1-4. doi: 10.1016/j.cca.2013.03.023. Epub 2013 Mar 29. 2013
  2. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. Stillman MJ, Day SP, Schutzbank TE. J Clin Virol. 2009 Jul;45 Suppl 1:S73-7. doi: 10.1016/S1386-6532(09)70011-3. 2009
  3. A comparative study of five technologically diverse CFTR testing platforms. Johnson MA, Yoshitomi MJ, Richards CS. J Mol Diagn. 2007 Jul;9(3):401-7. 2007
  4. A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput. Pati N, Schowinsky V, Kokanovic O, Magnuson V, Ghosh S. J Biochem Biophys Methods. 2004 Jul 30;60(1):1-12. 2004
  5. A comparison of eubacterial and archaeal structure-specific 5′-exonucleases. Kaiser MW, Lyamicheva N, Ma W, Miller C, Neri B, Fors L, Lyamichev VI. J Biol Chem. 1999 Jul 23;274(30):21387-94. 1999
  6. A comparison of simple sequence repeat and single nucleotide polymorphism marker technologies for the genotypic analysis of maize (Zea mays L.). Jones ES, Sullivan H, Bhattramakki D, Smith JS. Theor Appl Genet. 2007 Aug;115(3):361-71. Epub 2007 May 22.  2007
  7. A comparison of two methods to determine the presence of high-risk HPV cervical infections. Johnson LR, Starkey CR, Palmer J, Taylor J, Stout S, Holt S, Hendren R, Bock B, Waibel E, Tyree G, Miller GC. Am J Clin Pathol. 2008 Sep;130(3):401-8. doi: 10.1309/4DXEAFG2JXYF34N3. 2008
  8. A Haplotype Map of the Human Genome. The International HapMap Consortium. Nature 437, 1299-1320. 2005 2005
  9. A high-throughput SNP typing system for genome-wide association studies Ohnishi Y. Gan To Kagaku Ryoho. 2002 Nov;29(11):2031-6. 2002
  10. A modular approach to the synthesis of new reagents useful in the chemical synthesis of modified DNA probes: derivatives of 3-(tert-butyldimethylsiloxy)glutaric anhydride as versatile building blocks in the synthesis of new phosphoramidites and modified solid supports.  Skrzypczynski Z, Wayland S. Bioconjug Chem. 2004 May-Jun;15(3):583-93. 2004
  11. A multi-site study for detection of the factor V (Leiden) mutation from genomic DNA using a homogeneous invader microtiter plate fluorescence resonance energy transfer (FRET) assay. J Mol Diagn. 2000 May;2(2):97-104. Ledford M, Friedman KD, Hessner MJ, Moehlenkamp C, Williams TM, Larson RS. 2000
  12. A novel procedure for genotyping of single nucleotide polymorphisms in trisomy with genomic DNA and the invader assay. Duffy KJ, Littrell J, Locke A, Sherman SL, Olivier M. Nucleic Acids Res. 2008 Dec;36(22):e145. doi: 10.1093/nar/gkn736. Epub 2008 Oct 21. 2008
  13. A novel sensitive immunoassay method based on the Invader technique. Xie MJ, Fukui K, Horie M, Sakihama Y, Hashino K, Kimura H, Matsumoto K. Anal Biochem. 2008 Mar 15;374(2):278-84. Epub 2007 Nov 29. 008
  14. A population-based clinical trial comparing endocervical high-risk HPV testing using hybrid capture 2 and Cervista from the SHENCCAST II Study. Belinson JL, Wu R, Belinson SE, Qu X, Yang B, Du H, Wu R, Wang C, Zhang L, Zhou Y, Liu Y, Pretorius RG. Am J Clin Pathol. 2011 May;135(5):790-5. doi: 10.1309/AJCPKA6ATAPBZ6JQ. 2011
  15. A rapid, microplate SNP genotype assay for the leptinob allele. Oler AT, Attie AD. J Lipid Res. 2008 May;49(5):1126-9. doi: 10.1194/jlr.D800002-JLR200. Epub 2008 Feb 13. 2008
  16. A sensitive method for detecting variation in copy numbers of duplicated genes. Pielberg G, Day AE, Plastow GS, Andersson L. Genome Res. 2003 Sep;13(9):2171-7. 2003
  17. A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Dawson E, Chen Y, Hunt S, Smink LJ, Hunt A, Rice K, Livingston S, Bumpstead S, Bruskiewich R, Sham P, Ganske R, Adams M, Kawasaki K, Shimizu N, Minoshima S, Roe B, Bentley D, Dunham I. Genome Res. 2001 Jan;11(1):170-8. 2001
  18. A+U-rich instability elements differentially activate 5′-3′ and 3′-5′ mRNA decay. Murray EL, Schoenberg DR. Mol Cell Biol. 2007 Apr;27(8):2791-9. Epub 2007 Feb 12. 2007
  19. Accurate automated clustering of two-dimensional data for single-nucleotide polymorphism genotyping by a combination of clustering methods: evaluation by large-scale real data. Takitoh S, Fujii S, Mase Y, Takasaki J, Yamazaki T, Ohnishi Y, Yanagisawa M, Nakamura Y, Kamatani N.  Bioinformatics. 2007 Feb 15;23(4):408-13. 2007
  20. Adaptation of an Invader assay for the detection of African swine fever virus DNA. Hjertner B, Meehan B, McKillen J, McNeilly F, Belák S. J Virol Methods. 2005 Mar;124(1-2):1-10. Epub 2004 Dec 28. 2005
  21. Age-stratified performance of the Cervista HPV 16/18 genotyping test in women with ASC-US cytology. Einstein MH, Garcia FA, Mitchell AL, Day SP. Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1185-9. doi: 10.1158/1055-9965.EPI-11-0116. Epub 2011 Apr 28. 2011
  22. An accurate method for quantifying and analyzing copy number variation in porcine KIT by an oligonucleotide ligation assay. Seo BY, Park EW, Ahn SJ, Lee SH, Kim JH, Im HT, Lee JH, Cho IC, Kong IK, Jeon JT. BMC Genet. 2007 Nov 23;8:81. 2007
  23. An invasive cleavage assay for direct quantitation of specific RNAs. Eis PS, Olson MC, Takova T, Curtis ML, Olson SM, Vener TI, Ip HS, Vedvik KL, Bartholomay CT, Allawi HT, Ma WP, Hall JG, Morin MD, Rushmore TH, Lyamichev VI, Kwiatkowski RW. Nat Biotechnol. 2001 Jul;19(7):673-6. Erratum in: Nat Biotechnol 2002 Mar;20(3):307. 2001
  24. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A. J Mol Diagn. 2000 Aug;2(3):153-7. Huber S, McMaster KJ, Voelkerding KV. 2000
  25. Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples.  Bartholomew DA, Luff RD, Quigley NB, Curtis M, Olson MC. J Clin Virol. 2011 May;51(1):38-43. doi: 10.1016/j.jcv.2011.01.016. Epub 2011 Mar 4. 2011
  26. Analytical performance of the Investigational Use Only Cervista HPV HR test as determined by a multi-center study.  Day SP, Hudson A, Mast A, Sander T, Curtis M, Olson S, Chehak L, Quigley N, Ledford J, Yen-Lieberman B, Kohn D, Quigley DI, Olson M. J Clin Virol. 2009 Jul;45 Suppl 1:S63-72. doi: 10.1016/S1386-6532(09)70010-1. 2009
  27. Application of deafness diagnostic screening panel based on deafness mutation/gene database using invader assay. Abe S, Yamaguchi T, Usami S. Genet Test. 2007 Fall;11(3):333-40. 2007
  28. Application of the Invader RNA assay to the polarity of vertebrate mRNA decay. Murray EL, Schoenberg DR. Methods Mol Biol. 2008;419:259-76. doi: 10.1007/978-1-59745-033-1_18. 2008
  29. Assays for determining poly(A) tail length and the polarity of mRNA decay in mammalian cells. Murray EL, Schoenberg DR. Methods Enzymol. 2008;448:483-504. doi: 10.1016/S0076-6879(08)02624-4. 2008
  30. Assessment of clinical and analytical performance characteristics of an HPV genotyping test. Schutzbank TE, Ginocchio CC. Diagn Cytopathol. 2012 Apr;40(4):367-73. doi: 10.1002/dc.21661. Epub 2011 Apr 6. 2012
  31. Assessment of fine needle aspiration specimen adequacy for high-risk HPV detection and genotyping in oropharyngeal squamous cell carcinoma. Solomides CC, Bibbo M, Wang ZX. Acta Cytol. 2012;56(2):196-8. doi: 10.1159/000335730. Epub 2012 Feb 17. 2012
  32. Association between genetic determinants of peak height velocity during puberty and predisposition to adolescent idiopathic scoliosis. Mao S, Xu L, Zhu Z, Qian B, Qiao J, Yi L, Qiu Y. Spine (Phila Pa 1976). 2013 Jan 24. [Epub ahead of print] 2013
  33. Association between human papillomavirus DNA and temporal arteritis. Mohammadi A, Pfeifer JD, Lewis JS Jr. BMC Musculoskelet Disord. 2012 Jul 25;13:132. doi: 10.1186/1471-2474-13-132. 2012
  34. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Omori S, Tanaka Y, Takahashi A, Hirose H, Kashiwagi A, Kaku K, Kawamori R, Nakamura Y, Maeda S. Diabetes. 2008 Mar;57(3):791-5. Epub 2007 Dec 27. 2008
  35. Association of rs11190870 near LBX1 with adolescent idiopathic scoliosis susceptibility in a Han Chinese population. Jiang H, Qiu X, Dai J, Yan H, Zhu Z, Qian B, Qiu Y. Eur Spine J. 2013 Feb;22(2):282-6. doi: 10.1007/s00586-012-2532-4. Epub 2012 Oct 21. 2013
  36. Automated SNPs typing system based on the Invader assay. Nakahara H, Hosono N, Kitayama T, Sekiguchi K, Kubo M, Takahashi A, Nakamura Y, Yamano Y, Kai K. Leg Med (Tokyo). 2009 Apr;11 Suppl 1:S111-4. doi: 10.1016/j.legalmed.2009.02.020. Epub 2009 Mar 10. 2009
  37. Barking up the wrong genome–we are not alone. Li-Wan-Po A, Farndon P. J Clin Pharm Ther. 2011 Apr;36(2):125-7. doi: 10.1111/j.1365-2710.2010.01240.x. Epub 2011 Jan 16. 2011
  38. BCR-ABL1 mutations in patients with imatinib-resistant Philadelphia chromosome-positive leukemia by use of the PCR-Invader assay. Ono T, Miyawaki S, Kimura F, Kanamori H, Ohtake S, Kitamura K, Fujita H, Sugiura I, Usuki K, Emi N, Tamaki S, Aoyama Y, Kaya H, Naoe T, Tadokoro K, Yamaguchi T, Ohno R, Ohnishi K; Japan Adult Leukemia Study Group. Leuk Res. 2011 May;35(5):598-603. doi: 10.1016/j.leukres.2010.12.006. Epub 2011 Jan 15. 2011
  39. Case-control association study of 65 candidate genes revealed a possible association of a SNP of HTR5A to be a factor susceptible to bipolar disease in Bulgarian population. Yosifova A, Mushiroda T, Stoianov D, Vazharova R, Dimova I, Karachanak S, Zaharieva I, Milanova V, Madjirova N, Gerdjikov I, Tolev T, Velkova S, Kirov G, Owen MJ, O’Donovan MC, Toncheva D, Nakamura Y. J Affect Disord. 2009 Sep;117(1-2):87-97. doi: 10.1016/j.jad.2008.12.021. Epub 2009 Mar 28. 2009
  40. CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. Kuo HC, Yu HR, Juo SH, Yang KD, Wang YS, Liang CD, Chen WC, Chang WP, Huang CF, Lee CP, Lin LY, Liu YC, Guo YC, Chiu CC, Chang WC. J Hum Genet. 2011 Feb;56(2):161-5. doi: 10.1038/jhg.2010.154. Epub 2010 Dec 16. 2011
  41. Cervista HR and HPV 16/18 assays vs hybrid capture 2 assay: outcome comparison in women with negative cervical cytology. Kurian EM, Caporelli ML, Baker S, Woda B, Cosar EF, Hutchinson L. Am J Clin Pathol. 2011 Nov;136(5):808-16. doi: 10.1309/AJCPCQD7B7DPVHLH. 2011
  42. Characterization of cytochrome P450 2D6 alleles using the Invader system. Nevilie M, Selzer R, Aizenstein B, Maguire M, Hogan K, Walton R, Welsh K, Neri B, de Arruda M. Biotechniques. 2002 Jun;Suppl:34-8, 40-3. 2002
  43. Classification of hepatitis B virus genotypes by the PCR-Invader method with genotype-specific probes. Tadokoro K, Kobayashi M, Yamaguchi T, Suzuki F, Miyauchi S, Egashira T, Kumada H. J Virol Methods. 2006 Dec;138(1-2):30-9. Epub 2006 Aug 24. 2006
  44. Cleavase fragment length polymorphism analysis for genotyping and mutation detection. Heisler L, Lee CH. Methods Mol Biol. 2002;187:165-78. No abstract available. 2002
  45. Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens. Youens KE, Hosler GA, Washington PJ, Jenevein EP, Murphy KM. J Mol Diagn. 2011 Mar;13(2):160-6. doi: 10.1016/j.jmoldx.2010.11.016. 2011
  46. Clinical laboratory experience with cervista HPV HR as a function of cytological classification: comparison with retrospective digene HC2 high-risk HPV DNA test data. Du Chateau BK, Schroeder ER, Munson E. J Clin Microbiol. 2013 Mar;51(3):1057-8. doi: 10.1128/JCM.02836-12. Epub 2012 Dec 19. 2013
  47. Clinical performance characteristics of the Cervista HPV HR test kit in cervical cancer screening in China. Zhao J, Zhang X, Ma J, Liu G, Yao D, Zhang W, Wang J, Wei L, Zhao Y, Zeng Y, Liao Q. J Low Genit Tract Dis. 2012 Oct;16(4):358-63. 2012
  48. Clinical profile of hearing loss in children with congenital cytomegalovirus (CMV) infection: CMV DNA diagnosis using preserved umbilical cord. Furutate S, Iwasaki S, Nishio SY, Moteki H, Usami S. Acta Otolaryngol. 2011 Sep;131(9):976-82. doi: 10.3109/00016489.2011.583268. Epub 2011 May 26. 2011
  49. Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC. Gynecol Oncol. 2010 Aug 1;118(2):116-22. doi: 10.1016/j.ygyno.2010.04.013. Epub 2010 May 21. 2010
  50. Clinical, genetic, and pharmacogenetic applications of the Invader assay. Kwiatkowski RW, Lyamichev V, de Arruda M, Neri B. Mol Diagn. 1999 Dec;4(4):353-64. Review. 1999
  51. Colonisation of the oral cavity by periodontopathic bacteria in complete denture wearers. Yasui M, Ryu M, Sakurai K, Ishihara K. Gerodontology. 2012 Jun;29(2):e494-502. doi: 10.1111/j.1741-2358.2011.00506.x. Epub 2011 Sep 19. 2012
  52. Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. Osawa N, Koya D, Araki S, Uzu T, Tsunoda T, Kashiwagi A, Nakamura Y, Maeda S. J Hum Genet. 2007;52(2):143-51. Epub 2006 Dec 2. 2007
  53. Common null variant, Arg192Stop, in a G-protein coupled receptor, olfactory receptor 1B1, associated with decreased serum cholinesterase activity. Koyano S, Emi M, Saito T, Makino N, Toriyama S, Ishii M, Kubota I, Kato T, Kawata S. Hepatol Res. 2008 Jul;38(7):696-703. doi: 10.1111/j.1872-034X.2008.00327.x. Epub 2008 Mar 4. 2008
  54. Comparative evaluation of three commercially available methodologies for hepatitis C virus genotyping. Schutzbank TE, Sefers SE, Kahmann N, Li H, Tang YW. J Clin Microbiol. 2006 Oct;44(10):3797-8. 2006
  55. Comparative quantitative analysis of 14 types of human papillomavirus by real-time polymerase chain reaction monitoring Invader reaction (Q-Invader assay). Tadokoro K, Akutsu Y, Tanaka K, Saito T, Yamaguchi T, Egashira T, Ishiwata I, Hara T. Diagn Microbiol Infect Dis. 2010 Jan;66(1):58-64. doi: 10.1016/j.diagmicrobio.2009.05.001. Epub 2009 Sep 3. 2010
  56. Comparative quantitative analysis of hepatitis C mutations at amino acids 70 and 91 in the core region by the Q-Invader assay. Tadokoro K, Kobayashi M, Suzuki F, Tanaka C, Yamaguchi T, Nagano M, Egashira T, Kumada H. J Virol Methods. 2013 Apr;189(1):221-7. doi: 10.1016/j.jviromet.2012.10.011. Epub 2012 Nov 2. 2013
  57. Comparative study of the cervista and hybrid capture 2 methods in detecting high-risk human papillomavirus in cervical lesions. Tao K, Yang J, Yang H, Guo ZH, Hu YM, Tan ZY, Zhang F, Duan JL. Diagn Cytopathol. 2013 Aug 1. doi: 10.1002/dc.23025. [Epub ahead of print] 2013
  58. Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping. Maurice CB, Barua PK, Simses D, Smith P, Howe JG, Stack G. Clin Chim Acta. 2010 Jul 4;411(13-14):947-54. doi: 10.1016/j.cca.2010.03.005. Epub 2010 Mar 11. 2010
  59. Comparison of Commercial Hybridization and Automated Transcription-mediated Amplification Modalities for Detection of High-risk Human Papillomavirus Nucleic Acid. Munson E, Kroeger L, Balzer S, Amrhein R, Munson KL, Napierala M, Hudspeth R, Dillon PJ. J Clin Microbiol. 2013 Nov 6. [Epub ahead of print]  2013
  60. Comparison of detection platforms and post-polymerase chain reaction DNA purification methods for use in conjunction with Cleavase fragment length polymorphism analysis. Sander T, Olson S, Hall J, Siebert M, Grooms K, Heisler L, de Arruda M, Neri B. Electrophoresis. 1999 Jun;20(6):1131-40. 1999
  61. Comparison of methods trial for high-risk HPV. Kurtycz DF, Smith M, He R, Miyazaki K, Shalkham J. Diagn Cytopathol. 2010 Feb;38(2):104-8. doi: 10.1002/dc.21161. 2010
  62. Comparison of molecular methods for detection of HPV in oral and oropharyngeal squamous cell carcinoma. Kingma DW, Allen RA, Caughron SK, Melby M, Moore WE, Gillies EM, Marlar RA, Dunn TS. Diagn Mol Pathol. 2010 Dec;19(4):218-23. doi: 10.1097/PDM.0b013e3181d0cd35. 2010
  63. Comparison of the Seeplex HPV4A ACE and the Cervista HPV assays for the detection of HPV in hybrid capture 2 positive media. Min KJ, So KA, Lee J, Hong HR, Hong JH, Lee JK, Kim AR. J Gynecol Oncol. 2012 Jan;23(1):5-10. doi: 10.3802/jgo.2012.23.1.5. Epub 2012 Jan 9. 2012
  64. Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. Ginocchio CC, Barth D, Zhang F. J Clin Microbiol. 2008 May;46(5):1641-6. doi: 10.1128/JCM.01824-07. Epub 2008 Mar 26. 2008
  65. Comparison of three methods for genotyping the UGT1A1 (TA)n repeat polymorphism. Baudhuin LM, Highsmith WE, Skierka J, Holtegaard L, Moore BE, O’Kane DJ. Clin Biochem. 2007 Jun;40(9-10):710-7. Epub 2007 Mar 23. 2007
  66. Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor alpha genes. Agarwal P, Oldenburg MC, Czarneski JE, Morse RM, Hameed MR, Cohen S, Fernandes H. Diagn Mol Pathol. 2000 Sep;9(3):158-64. 2000
  67. Criterion values for multiplex SNP genotyping by the invader assay. Nakahara H, Sekiguchi K, Hosono N, Kubo M, Takahashi A, Nakamura Y, Kasai K. Forensic Sci Int Genet. 2010 Feb;4(2):130-6. doi: 10.1016/j.fsigen.2009.07.005. Epub 2009 Aug 21. 2010
  68. Current limitations of SNP data from the public domain for studies of complex disorders: a test for ten candidate genes for obesity and osteoporosis. Dvornyk V, Long JR, Xiong DH, Liu PY, Zhao LJ, Shen H, Zhang YY, Liu YJ, Rocha-Sanchez S, Xiao P, Recker RR, Deng HW. BMC Genet. 2004 Feb 25;5:4. 2004
  69. Current Methods for Fluorescence-Based Universal Sequence-Dependent Detection of Nucleic Acids in Homogenous Assays and Clinical Applications. Faltin B, Zengerle R, von Stetten F. Clin Chem. 2013 Aug 12. [Epub ahead of print]   2013
  70. CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s). Leung A, Huang CK, Muto R, Liu Y, Pan Q. Diagn Mol Pathol. 2007 Sep;16(3):184-6. 2007
  71. CYP2D6 genotyping for functional-gene dosage analysis by allele copy number detection. Hosono N, Kato M, Kiyotani K, Mushiroda T, Takata S, Sato H, Amitani H, Tsuchiya Y, Yamazaki K, Tsunoda T, Zembutsu H, Nakamura Y, Kubo M. Clin Chem. 2009 Aug;55(8):1546-54. doi: 10.1373/clinchem.2009.123620. Epub 2009 Jun 18. 2009
  72. Deceiving high-grade cervical dysplasias identified as human papillomavirus non-16 and non-18 types by Invader human papillomavirus assays. Kitahara S, Chan RC, Nichols WS, Silva EG.   Ann Diagn Pathol. 2012 Apr;16(2):100-6. doi: 10.1016/j.anndiagpath.2011.09.003. Epub 2011 Dec 23. 2012
  73. Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus method. Tang YW, Allawi HT, DeLeon-Carnes M, Li H, Day SP, Schmid D. J Clin Virol. 2007 Oct;40(2):129-34. Epub 2007 Aug 28.  2007
  74. Detection of 677CT/1298AC “double variant” chromosomes: implications for interpretation of MTHFR genotyping results. Brown NM, Pratt VM, Buller A, Pike-Buchanan L, Redman JB, Sun W, Chen R, Crossley B, McGinniss MJ, Quan F, Strom CM. Genet Med. 2005 Apr;7(4):278-82. 2005
  75. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay. Patnaik M, Dlott JS, Fontaine RN, Subbiah MT, Hessner MJ, Joyner KA, Ledford MR, Lau EC, Moehlenkamp C, Amos J, Zhang B, Williams TM. J Mol Diagn. 2004 May;6(2):137-44. 2004
  76. Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. Schutzbank TE, Jarvis C, Kahmann N, Lopez K, Weimer M, Yount A. J Clin Microbiol. 2007 Dec;45(12):4067-9. Epub 2007 Oct 24.  2007
  77. Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis. Marshall DJ, Heisler LM, Lyamichev V, Murvine C, Olive DM, Ehrlich GD, Neri BP, de Arruda M. J Clin Microbiol. 1997 Dec;35(12):3156-62. 1997
  78. Determination of the factor V Leiden single-nucleotide polymorphism in a commercial clinical laboratory by use of NanoChip microelectronic array technology.  Evans JG, Lee-Tataseo C. Clin Chem. 2002 Sep;48(9):1406-11. 2002
  79. Development and clinical application of invader assay–detection of resistant mutation to clarithromycin in Helicobacter pylori. Egashira T. Rinsho Byori. 2006 Feb;54(2):176-83. 2006
  80. Development of a novel nano-Invader DNA chip system. Nomura S, Kondo M, Nagano M, Matsui K, Egashira T. J Biochem Biophys Methods. 2007 Aug 1;70(5):787-95. Epub 2007 Jun 2. 2007
  81. Development of new HLA-B*3505 genotyping method using Invader assay. Hosono N, Chantarangsu S, Kiyotani K, Takata S, Tsuchiya Y, Mahasirimongkol S, Chantratita W, Mushiroda T, Nakamura Y, Kubo M. Pharmacogenet Genomics. 2010 Oct;20(10):630-3. doi: 10.1097/FPC.0b013e32833ddc0a. 2010
  82. Development of new IL28B genotyping method using Invader Plus assay. Kani S, Tanaka Y, Matsuura K, Watanabe T, Yatsuhashi H, Orito E, Inose K, Motojuku N, Wakimoto Y, Mizokami M. Microbiol Immunol. 2012 May;56(5):318-23. doi: 10.1111/j.1348-0421.2012.00439.x.  2012
  83. Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage. Brow MA, Oldenburg MC, Lyamichev V, Heisler LM, Lyamicheva N, Hall JG, Eagan NJ, Olive DM, Smith LM, Fors L, Dahlberg JE.  J Clin Microbiol. 1996 Dec;34(12):3129-37. 1996
  84. Direct measurement of multiple mRNAs in nerve growth factor-induced PC12 cells using electrophoretic tags to monitor biomarkers of neuronal differentiation in 96-well format. Roux P, Menguy I, Soubigou S, Chinn J, Ricard S, Williams S, Guitton JD, Tian T, Singh S, Grépin C. Assay Drug Dev Technol. 2004 Dec;2(6):637-46. 2004
  85. Effect of glacial acetic acid treatment of liquid-based cytology collections on performance of Cervista HPV HR for detection of high-risk human papillomavirus. Munson E, Du Chateau BK, Nelson BE, Griep J, Czarnecka J, Amrhein RD, Schroeder ER. J Clin Microbiol. 2012 Jun;50(6):2129-31. doi: 10.1128/JCM.06719-11. Epub 2012 Mar 21. 2012
  86. Enabling large-scale pharmacogenetic studies by high-throughput mutation detection and genotyping technologies. Shi MM. Clin Chem. 2001 Feb;47(2):164-72. 2001
  87. Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Mein CA, Barratt BJ, Dunn MG, Siegmund T, Smith AN, Esposito L, Nutland S, Stevens HE, Wilson AJ, Phillips MS, Jarvis N, Law S, de Arruda M, Todd JA. Genome Res. 2000 Mar;10(3):330-43. 2000
  88. Evaluation of the invader assay for genotyping hepatitis C virus. Germer JJ, Majewski DW, Yung B, Mitchell PS, Yao JD. J Clin Microbiol. 2006 Feb;44(2):318-23. 2006
  89. Evaluation of the invader assay with the BACTEC MGIT 960 system for prompt isolation and identification of mycobacterial species from clinical specimens. Ichimura S, Nagano M, Ito N, Shimojima M, Egashira T, Miyamoto C, Ohkusu K, Ezaki T. J Clin Microbiol. 2007 Oct;45(10):3316-22. Epub 2007 Aug 8. 2007
  90. Evaluation of the invader assay, a linear signal amplification method, for identification of mutations associated with resistance to rifampin and isoniazid in Mycobacterium tuberculosis. Cooksey RC, Holloway BP, Oldenburg MC, Listenbee S, Miller CW. Antimicrob Agents Chemother. 2000 May;44(5):1296-301. 2000
  91. Evolving methods for single nucleotide polymorphism detection: Factor V Leiden mutation detection. Oh H, Smith CL. J Clin Lab Anal. 2011;25(4):259-88. doi: 10.1002/jcla.20470. 2011
  92. Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment. Minami Y, Kajiguchi T, Abe A, Ohno T, Kiyoi H, Naoe T. Int J Hematol. 2010 Nov;92(4):664-6. doi: 10.1007/s12185-010-0706-6. Epub 2010 Oct 22. 2010
  93. Experimental and theoretical analysis of the invasive signal amplification reaction. Lyamichev VI, Kaiser MW, Lyamicheva NE, Vologodskii AV, Hall JG, Ma WP, Allawi HT, Neri BP. Biochemistry. 2000 Aug 8;39(31):9523-32. 2000
  94. Exploiting the enzymatic recognition of an unnatural base pair to develop a universal genetic analysis system. Moser MJ, Marshall DJ, Grenier JK, Kieffer CD, Killeen AA, Ptacin JL, Richmond CS, Roesch EB, Scherrer CW, Sherrill CB, Van Hout CV, Zanton SJ, Prudent JR. Clin Chem. 2003 Mar;49(3):407-14. 2003
  95. Fluorescence studies of zinc finger peptides and proteins. Eis PS.    Methods Enzymol. 1997;278:330-43. Review. No abstract available. 1997
  96. Gene polymorphism of β-defensin-1 is associated with susceptibility to periodontitis in Japanese. Ikuta T, Inagaki Y, Tanaka K, Saito T, Nakajima Y, Bando M, Kido JI, Nagata T. Odontology. 2013 Nov 26. [Epub ahead of print] 2013
  97. Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Mochida S, Hashimoto M, Matsui A, Naito M, Inao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fujiwara K. Biochem Biophys Res Commun. 2004 Jan 23;313(4):1079-85. 2004
  98. Genome-wide linkage scan and association study of PARL to the expression of LHON families in Thailand. Phasukkijwatana N, Kunhapan B, Stankovich J, Chuenkongkaew WL, Thomson R, Thornton T, Bahlo M, Mushiroda T, Nakamura Y, Mahasirimongkol S, Tun AW, Srisawat C, Limwongse C, Peerapittayamongkol C, Sura T, Suthammarak W, Lertrit P. Hum Genet. 2010 Jul;128(1):39-49. doi: 10.1007/s00439-010-0821-8. Epub 2010 Apr 21. 2010
  99. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Hessner MJ, Budish MA, Friedman KD.  Clin Chem. 2000 Aug;46(8 Pt 1):1051-6. 2000
  100. Genotyping single-nucleotide polymorphisms by the invader assay with dual-color fluorescence polarization detection. Hsu TM, Law SM, Duan S, Neri BP, Kwok PY. Clin Chem. 2001 Aug;47(8):1373-7.          2001
  101. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. Cox DG, Crusius JB, Peeters PH, Bueno-de-Mesquita HB, Pena AS, Canzian F.       World J Gastroenterol. 2005 Oct 14;11(38):6003-8.        2005
  102. Hepatitis B virus genotyping: current methods and clinical implications. Guirgis BS, Abbas RO, Azzazy HM. Int J Infect Dis. 2010 Nov;14(11):e941-53. doi: 10.1016/j.ijid.2010.03.020. Epub 2010 Jul 31.          2010
  103. High-risk human papilloma virus DNA detection kit (cervista HPV HR) should be highly validated clinically in cervical cancer screening programs Zhao J, Zhang XG, Chen R, Bi H, Wang X, Liu GW, Yao DX, Zong Y, Liao QP. 2010
  104. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. Gold MA, Thomas MA, Huh WK, Sarto GE, Day SP. J Low Genit Tract Dis. 2013 Jan;17(1):51-7. doi: 10.1097/LGT.0b013e31824ddbe0. 2013
  105. High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder. Chapman-Fredricks JR, Cioffi-Lavina M, Accola MA, Rehrauer WM, Garcia-Buitrago MT, Gomez-Fernandez C, Ganjei-Azar P, Jordà M. Arch Pathol Lab Med. 2013 Aug;137(8):1088-93. doi: 10.5858/arpa.2012-0122-OA. 2013
  106. High-throughput genotyping of single nucleotide polymorphisms using new biplex invader technology. Olivier M, Chuang LM, Chang MS, Chen YT, Pei D, Ranade K, de Witte A, Allen J, Tran N, Curb D, Pratt R, Neefs H, de Arruda Indig M, Law S, Neri B, Wang L, Cox DR. Nucleic Acids Res. 2002 Jun 15;30(12):e53. 2002
  107. HPV genotype distribution in oral and oropharyngeal squamous cell carcinoma using seven in vitro amplification assays. Kingma DW, Allen RA, Moore W, Caughron SK, Melby M, Gillies EM, Marlar RA, Dunn ST. Anticancer Res. 2010 Dec;30(12):5099-104. 2010
  108. Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay. Wong AK, Chan RC, Nichols WS, Bose S. J Clin Microbiol. 2008 Mar;46(3):869-75. doi: 10.1128/JCM.01424-07. Epub 2008 Jan 3. 2008
  109. Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Wong AK, Chan RC, Aggarwal N, Singh MK, Nichols WS, Bose S. Mod Pathol. 2010 Jan;23(1):144-50. doi: 10.1038/modpathol.2009.143. Epub 2009 Oct 16.      2010
  110. Identification of 23 mycobacterial species by Invader assay with targeting 16S rRNA gene and ITS-1 region–comparison with DDH method in clinical isolates Nagano M, Ichimura S, Ito N, Tomii T, Kazumi Y, Takei K, Abe C, Sugawara I. Kekkaku. 2008 Jul;83(7):487-96. 2008
  111. IL28B polymorphism is associated with fatty change in the liver of chronic hepatitis C patients. Ohnishi M, Tsuge M, Kohno T, Zhang Y, Abe H, Hyogo H, Kimura Y, Miki D, Hiraga N, Imamura M, Takahashi S, Ochi H, Hayes CN, Tanaka S, Arihiro K, Chayama K. J Gastroenterol. 2012 Jul;47(7):834-44. doi: 10.1007/s00535-012-0550-y. Epub 2012 Feb 18. 2012
  112. Impact of Allele Copy Number of Polymorphisms in FCGR3A and FCGR3B Genes on Susceptibility to Ulcerative Colitis. Asano K, Matsumoto T, Umeno J, Hirano A, Esaki M, Hosono N, Matsui T, Kiyohara Y, Nakamura Y, Kubo M, Kitazono T. Inflamm Bowel Dis. 2013 Sep;19(10):2061-2068. 2013
  113. Impact of LIMK1, MMP2 and TNF-α variations for intracranial aneurysm in Japanese population. Low SK, Zembutsu H, Takahashi A, Kamatani N, Cha PC, Hosono N, Kubo M, Matsuda K, Nakamura Y. J Hum Genet. 2011 Mar;56(3):211-6. doi: 10.1038/jhg.2010.169. Epub 2011 Jan 13. 2011
  114. Improved diagnosis for nine viral diseases considered as notifiable by the world organization for animal health. Rodriguez-Sanchez B, Sanchez-Vizcaino JM, Uttenthal A, Rasmussen TB, Hakhverdyan M, King DP, Ferris NP, Ebert K, Reid SM, Kiss I, Brocchi E, Cordioli P, Hjerner B, McMenamy M, McKillen J, Ahmed JS, Belak S. Transbound Emerg Dis. 2008 Aug;55(5-6):215-25. doi: 10.1111/j.18651682.2008.01037.x. 2008
  115. Improved sensitivity of vaginal self-collection and high-risk human papillomavirus testing. Belinson JL, Du H, Yang B, Wu R, Belinson SE, Qu X, Pretorius RG, Yi X, Castle PE. Int J Cancer. 2012 Apr 15;130(8):1855-60. doi: 10.1002/ijc.26202. Epub 2011 Aug 16.  2012
  116. Inflammation as a risk factor for myocardial infarction. Tanaka T, Ozaki K. J Hum Genet. 2006;51(7):595-604. Epub 2006 Jun 13. 2006
  117. MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC Study. Hishida A, Okada R, Guang Y, Naito M, Wakai K, Hosono S, Nakamura K, Turin TC, Suzuki S, Niimura H, Mikami H, Otonari J, Kuriyama N, Katsuura S, Kubo M, Tanaka H, Hamajima N. Int Urol Nephrol. 2013 Dec;45(6):1613-20. doi: 10.1007/s11255-013-0432-0. Epub 2013 Apr 18.   2013
  118. Invader Assay Day, S., and M. Mast Encyclopedia of Diagnostic Genomics and Proteomics. Marcel Dekker, Inc., New York. 2004
  119. Invader assay for RNA quantitation. Olson MC, Takova T, Chehak L, Curtis ML, Olson SM, Kwiatkowski RW. Methods Mol Biol. 2004;258:53-69. 2004
  120. Invader assay for single-nucleotide polymorphism genotyping and gene copy number evaluation. Mast A, de Arruda M. Methods Mol Biol. 2006;335:173-86. Review. 2006
  121. Invader assay for SNP genotyping. Lyamichev V, Neri B. Methods Mol Biol. 2003;212:229-40. No abstract available. 2003
  122. Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance. Wong AK, Chan RC, Nichols WS, Bose S. Cancer. 2009 Feb 15;115(4):823-32. doi: 10.1002/cncr.24091. 2009
  123. Invader plus method detects herpes simplex virus in cerebrospinal fluid and simultaneously differentiates types 1 and 2. Allawi HT, Li H, Sander T, Aslanukov A, Lyamichev VI, Blackman A, Elagin S, Tang YW. J Clin Microbiol. 2006 Sep;44(9):3443-7. 2006
  124. Invader technology for DNA and RNA analysis: principles and applications. de Arruda M, Lyamichev VI, Eis PS, Iszczyszyn W, Kwiatkowski RW, Law SM, Olson MC, Rasmussen EB. Expert Rev Mol Diagn. 2002 Sep;2(5):487-96. Review. 2002
  125. Invader UGT1A1 molecular assay for irinotecan toxicity. A genetic test for an increased risk of toxicity from the cancer chemotherapy drug irinotecan (Camptosar). [No authors listed] Med Lett Drugs Ther. 2006 May 8;48(1234):39-40. No abstract available. 2006
  126. Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese – cross-sectional data from the J-MICC study.   Hishida A, Okada R, Naito M, Morita E, Wakai K, Hamajima N, Hosono S, Nanri H, Turin TC, Suzuki S, Kuwabara K, Mikami H, Budhathoki S, Watanabe I, Arisawa K, Kubo M, Tanaka H. J Clin Biochem Nutr. 2013 Jul;53(1):15-20. doi: 10.3164/jcbn.13-17. Epub 2013 Jun 1. 2013
  127. Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population. Hara M, Higaki Y, Taguchi N, Shinchi K, Morita E, Naito M, Hamajima N, Takashima N, Suzuki S, Nakamura A, Ohnaka K, Uemura H, Nishida H, Hosono S, Mikami H, Kubo M, Tanaka H; Japan Multi-Institutional Collaborative Cohort (J-MICC) Study Group.   J Epidemiol. 2012;22(6):523-31. doi: 10.2188/jea.JE20120078. Epub 2012 Sep 22. 2012
  128. KCNQ1 SNPS and susceptibility to diabetic nephropathy in East Asians with type 2 diabetes. Lim XL, Nurbaya S, Salim A, Tai ES, Maeda S, Nakamura Y, Ng DP. Diabetologia. 2012 Sep;55(9):2402-6. doi: 10.1007/s00125-012-2602-5. Epub 2012 Jun 14. 2012
  129. Lack of association between adolescent idiopathic scoliosis and previously reported single nucleotide polymorphisms in MATN1, MTNR1B, TPH1, and IGF1 in a Japanese population. Takahashi Y, Matsumoto M, Karasugi T, Watanabe K, Chiba K, Kawakami N, Tsuji T, Uno K, Suzuki T, Ito M, Sudo H, Minami S, Kotani T, Kono K, Yanagida H, Taneichi H, Takahashi A, Toyama Y, Ikegawa S. J Orthop Res. 2011 Jul;29(7):1055-8. doi: 10.1002/jor.21347. Epub 2011 Feb 9. 2011
  130. Large scale genotyping study for asthma in the Japanese population. Imada Y, Fujimoto M, Hirata K, Hirota T, Suzuki Y, Saito H, Matsumoto K, Akazawa A, Katsunuma T, Yoshihara S, Ebisawa M, Shibasaki M, Arinami T, Tamari M, Noguchi E. BMC Res Notes. 2009 Mar 31;2:54. doi: 10.1186/1756-0500-2-54. 2009
  131. Large-scale SNP scoring from unamplified genomic DNA. Fors L, Lieder KW, Vavra SH, Kwiatkowski RW. Pharmacogenomics. 2000 May;1(2):219-29. Review. 2000
  132. Limited effects of frequent CYP2D6*36-*10 tandem duplication allele on in vivo dextromethorphan metabolism in a Japanese population. Kiyotani K, Shimizu M, Kumai T, Kamataki T, Kobayashi S, Yamazaki H. Eur J Clin Pharmacol. 2010 Oct;66(10):1065-8. doi: 10.1007/s00228-010-0876-4. Epub 2010 Aug 11. 2010
  133. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. Allawi HT, Dong F, Ip HS, Neri BP, Lyamichev VI. RNA. 2001 Feb;7(2):314-27. 2001
  134. Methods to detect and analyze copy number variations at the genome-wide and locus-specific levels. Lee JH, Jeon JT. Cytogenet Genome Res. 2008;123(1-4):333-42. doi: 10.1159/000184725. Epub 2009 Mar 11. 2008
  135. Modeling of flap endonuclease interactions with DNA substrate. Allawi HT, Kaiser MW, Onufriev AV, Ma WP, Brogaard AE, Case DA, Neri BP, Lyamichev VI. J Mol Biol. 2003 May 2;328(3):537-54.   2003
  136. Molecular diagnosis of viral diseases, present trends and future aspects A view from the OIE Collaborating Centre for the Application of Polymerase Chain Reaction Methods for Diagnosis of Viral Diseases in Veterinary Medicine. Belák S. Vaccine. 2007 Jul 26;25(30):5444-52. Epub 2006 Dec 28. Review. 2007
  137. Molecular diagnostic testing for inherited thrombophilia using Invader. Keller MA. Methods Mol Med. 2005;114:107-19. 2005
  138. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan. Mabuchi H, Nohara A, Noguchi T, Kobayashi J, Kawashiri MA, Tada H, Nakanishi C, Mori M, Yamagishi M, Inazu A, Koizumi J; Hokuriku FH Study Group. Atherosclerosis. 2011 Feb;214(2):404-7. doi: 10.1016/j.atherosclerosis.2010.11.005. Epub 2010 Nov 13.      2011
  139. Multiplex mRNA assay using electrophoretic tags for high-throughput gene expression analysis. Tian H, Cao L, Tan Y, Williams S, Chen L, Matray T, Chenna A, Moore S, Hernandez V, Xiao V, Tang M, Singh S. Nucleic Acids Res. 2004 Sep 8;32(16):e126. 2004
  140. Multiplex PCR-based real-time invader assay (mPCR-RETINA): a novel SNP-based method for detecting allelic asymmetries within copy number variation regions. Hosono N, Kubo M, Tsuchiya Y, Sato H, Kitamoto T, Saito S, Ohnishi Y, Nakamura Y. Hum Mutat. 2008 Jan;29(1):182-9. 2008
  141. Multiplexed gene expression analysis using the invader RNA assay with MALDI-TOF mass spectrometry detection. Berggren WT, Takova T, Olson MC, Eis PS, Kwiatkowski RW, Smith LM. Anal Chem. 2002 Apr 15;74(8):1745-50. 2002
  142. Multisite study for genotyping of the factor II (prothrombin) G20210A mutation by the invader assay. Hessner MJ, Friedman KD, Voelkerding KV, Huber S, Ryan D, Nuccie B, Ledford M. Clin Chem. 2001 Nov;47(11):2048-50. 2001
  143. New approaches for genotyping paraffin wax embedded breast tissue from patients with cancer: the Iowa women’s health study. Thyagarajan B, Anderson KE, Kong F, Selk FR, Lynch CF, Gross MD. J Clin Pathol. 2005 Sep;58(9):955-61. 2005
  144. New Cleavase Fragment Length Polymorphism method improves the mutation detection assay. Oldenburg MC, Siebert M. Biotechniques. 2000 Feb;28(2):351-7. 2000
  145. New pharmacogenetic test for detecting an HLA-A*31: 01 allele using the InvaderPlus assay. Aoki M, Hosono N, Takata S, Nakamura Y, Kamatani N, Kubo M. Pharmacogenet Genomics. 2012 Jun;22(6):441-6. doi: 10.1097/FPC.0b013e3283527c40. 2012
  146. New reagents for the introduction of reactive functional groups into chemically synthesized DNA probes. Skrzypczynski Z, Wayland S. Bioconjug Chem. 2003 May-Jun;14(3):642-52. 2003
  147. No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women’s Health Study. Thyagarajan B, Anderson KE, Folsom AR, Jacobs DR Jr, Lynch CF, Bargaje A, Khaliq W, Gross MD. Cancer Detect Prev. 2006;30(4):313-21. Epub 2006 Sep 11. 2006
  148. Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay. Ryan D, Nuccie B, Arvan D. Mol Diagn. 1999 Jun;4(2):135-44. 1999
  149. Novel and alternate SNP and genetic technologies. Breen G. Psychiatr Genet. 2002 Jun;12(2):83-8.  2002
  150. Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient. Uchida Y, Kouyama JI, Naiki K, Sugawara K, Inao M, Nakayama N, Mochida S. Hepatol Res. 2013 Sep 10. doi: 10.1111/hepr.12238. [Epub ahead of print] 2013
  151. Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. Seno H, Satoh K, Tsuji S, Shiratsuchi T, Harada Y, Hamajima N, Sugano K, Kawano S, Chiba T. J Gastroenterol Hepatol. 2007 May;22(5):729-37. 2007
  152. Outlier SNPs show more genetic structure between two Bay of Fundy metapopulations of Atlantic salmon than do neutral SNPs. Freamo H, O’Reilly P, Berg PR, Lien S, Boulding EG. Mol Ecol Resour. 2011 Mar;11 Suppl 1:254-67. doi: 10.1111/j.1755-0998.2010.02952.x. 2011
  153. Parallel single nucleotide polymorphism genotyping by surface invasive cleavage with universal detection. Chen Y, Shortreed MR, Olivier M, Smith LM. Anal Chem. 2005 Apr 15;77(8):2400-5. 2005
  154. Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose. King CR, Porche-Sorbet RM, Gage BF, Ridker PM, Renaud Y, Phillips MS, Eby C. Am J Clin Pathol. 2008 Jun;129(6):876-83. doi: 10.1309/1E34UAPR06PJ6HML. 2008
  155. Perioperative genomic profiles using structure-specific oligonucleotide probes. Hogan KJ, Burmester JK, Caldwell MD, Hogan QH, Coursin DB, Green DN, Selzer RM, Broderick TP, Rusy DA, Poroli M, Lutz AL, Sanders AM, Oldenburg MC, Koelbl JA, de Arruda-Indig M, Halsey JL, Day SP, Domanico MJ. Clin Med Res. 2009 Sep;7(3):69-84. doi: 10.3121/cmr.2009.837. Epub 2009 May 27.  2009
  156. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, Kwiatkowski RW, Sander TJ, de Arruda M, Arco DA, Neri BP, Brow MA. Nat Biotechnol. 1999 Mar;17(3):292-6. 1999
  157. Polymorphisms of GSTP1, ERCC2 and TS-3’UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients.   Kumamoto K, Ishibashi K, Okada N, Tajima Y, Kuwabara K, Kumagai Y, Baba H, Haga N, Ishida H. Oncol Lett. 2013 Sep;6(3):648-654. Epub 2013 Jul 15. 2013
  158. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn’s disease in Japanese patients. Yamazaki K, Takahashi A, Takazoe M, Kubo M, Onouchi Y, Fujino A, Kamatani N, Nakamura Y, Hata A. Gut. 2009 Feb;58(2):228-32. doi: 10.1136/gut.2007.140764. Epub 2008 Oct 20. 2009
  159. Polymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC Study. Hishida A, Wakai K, Naito M, Tamura T, Kawai S, Hamajima N, Oze I, Imaizumi T, Turin TC, Suzuki S, Kheradmand M, Mikami H, Ohnaka K, Watanabe Y, Arisawa K, Kubo M, Tanaka H. PPAR Res. 2013;2013:980471. Epub 2013 Nov 7. 2013
  160. Putting the Invader assay to work: laboratory application and data management. Zhang Y, Smith E, Olivier M. Methods Mol Biol. 2009;578:363-77. doi: 10.1007/978-1-60327-411-1_22. 2009
  161. Quantification of microRNAs, splicing isoforms, and homologous mRNAs with the invader assay. Eis PS, Garcia-Blanco MA. Methods Mol Biol. 2008;488:279-318. doi: 10.1007/978-1-60327-475-3_20. 2008
  162. Quantification of periodontopathic bacteria in saliva using the invader assay. Tada A, Takeuchi H, Shimizu H, Tadokoro K, Tanaka K, Kawamura K, Yamaguchi T, Egashira T, Nomura Y, Hanada N. Department of Health Science, Hyogo University, Hyogo, Japan. atada@hyogo-dai.ac.jp 2012
  163. Quantitation of HBsAg predicts response to entecavir therapy in HBV genotype C patients. Orito E, Fujiwara K, Kanie H, Ban T, Yamada T, Hayashi K. World J Gastroenterol. 2012 Oct 21;18(39):5570-5. doi: 10.3748/wjg.v18.i39.5570. 2012
  164. Quantitation of microRNAs using a modified Invader assay. Allawi HT, Dahlberg JE, Olson S, Lund E, Olson M, Ma WP, Takova T, Neri BP, Lyamichev VI. RNA. 2004 Jul;10(7):1153-61. 2004
  165. Quantitation of viral load by real-time PCR-monitoring Invader reaction. Tadokoro K, Yamaguchi T, Egashira T, Hara T. J Virol Methods. 2009 Feb;155(2):182-6. doi: 10.1016/j.jviromet.2008.10.017. Epub 2008 Dec 4. 2009
  166. RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism. Aslanukov A, Bhowmick R, Guruju M, Oswald J, Raz D, Bush RA, Sieving PA, Lu X, Bock CB, Ferreira PA. PLoS Genet. 2006 Oct;2(10):e177. Epub 2006 Sep 1. 2006
  167. Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay. Tadokoro K, Suzuki F, Kobayashi M, Yamaguchi T, Nagano M, Egashira T, Kumada H. J Virol Methods. 2011 Jan;171(1):67-73. doi: 10.1016/j.jviromet.2010.10.001. Epub 2010 Oct 13. 2011
  168. Rapid detection of UGT1A1 gene polymorphisms by newly developed Invader assay.   Hasegawa Y, Sarashina T, Ando M, Kitagawa C, Mori A, Yoneyama M, Ando Y, Shimokata K. Clin Chem. 2004 Aug;50(8):1479-80. No abstract available. 2004
  169. Rapid quantification of periodontitis-related bacteria using a novel modification of Invader PLUS technologies. Tadokoro K, Yamaguchi T, Kawamura K, Shimizu H, Egashira T, Minabe M, Yoshino T, Oguchi H.   Microbiol Res. 2010;165(1):43-9. doi: 10.1016/j.micres.2008.06.001. Epub 2008 Aug 20. 2010
  170. Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber’s hereditary optic neuropathy using the Invader technology. Mashima Y, Nagano M, Funayama T, Zhang Q, Egashira T, Kudho J, Shimizu N, Oguchi Y. Clin Biochem. 2004 Apr;37(4):268-76.   2004
  171. Rate of detection of high-risk HPV with two assays in women ≥ 30 years of age. Quigley NB, Potter NT, Chivukula M, Knight MZ, Welch JR, Olson MC J Clin Virol. 2011 Sep;52(1):23-7. doi: 10.1016/j.jcv.2011.05.014. Epub 2011 Jul 2. 2011
  172. Replication study for the association of a single-nucleotide polymorphism, rs3746876, within KCNJ15, with susceptibility to type 2 diabetes in a Japanese population. Fukuda H, Imamura M, Tanaka Y, Iwata M, Hirose H, Kaku K, Maegawa H, Watada H, Tobe K, Kashiwagi A, Kawamori R, Maeda S. J Hum Genet. 2013 Jul;58(7):490-3. doi: 10.1038/jhg.2013.28. Epub 2013 Apr 18. 2013
  173. RNA template-dependent 5′ nuclease activity of Thermus aquaticus and Thermus thermophilus DNA polymerases. Ma WP, Kaiser MW, Lyamicheva N, Schaefer JJ, Allawi HT, Takova T, Neri BP, Lyamichev VI. J Biol Chem. 2000 Aug 11;275(32):24693-700. 2000
  174. Screening for adverse reactions to irinotecan treatment using the Invader UGT1A1 Molecular Assay. Hasegawa Y, Ando Y, Shimokata K. Expert Rev Mol Diagn. 2006 Jul;6(4):527-33. Review. 2006
  175. Secondary structure prediction and structure-specific sequence analysis of single-stranded DNA. Dong F, Allawi HT, Anderson T, Neri BP, Lyamichev VI. Nucleic Acids Res. 2001 Aug 1;29(15):3248-57. 2001
  176. Self-collection of test material. Supplement to cervical cancer screening Mangold BR. Pathologe. 2013 Nov;34(6):558-62. doi: 10.1007/s00292-013-1857-z. 2013
  177. Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Hall JG, Eis PS, Law SM, Reynaldo LP, Prudent JR, Marshall DJ, Allawi HT, Mast AL, Dahlberg JE, Kwiatkowski RW, de Arruda M, Neri BP, Lyamichev VI. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8272-7. 2000
  178. Sensitive discrimination between cytosine and 5-methylcytosine in DNA by a modified invader method. Yamada H, Tanabe K, Nishimoto S. Nucleic Acids Symp Ser (Oxf). 2006;(50):163-4. 2006
  179. Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR. Yamamoto M, Kakihana K, Ohashi K, Yamaguchi T, Tadokoro K, Akiyama H, Sakamaki H. Int J Hematol. 2009 May;89(4):482-8. doi: 10.1007/s12185-009-0290-9. Epub 2009 Apr 3. 2009
  180. Simultaneous screening of multiple mutations by invader assay improves molecular diagnosis of hereditary hearing loss: a multicenter study. Usami S, Nishio SY, Nagano M, Abe S, Yamaguchi T; Deafness Gene Study Consortium. PLoS One. 2012;7(2):e31276. doi: 10.1371/journal.pone.0031276. Epub 2012 Feb 24. 2012
  181. Single nucleotide polymorphisms in the gene encoding Krüppel-like factor 7 are associated with type 2 diabetes. Kanazawa A, Kawamura Y, Sekine A, Iida A, Tsunoda T, Kashiwagi A, Tanaka Y, Babazono T, Matsuda M, Kawai K, Iiizumi T, Fujioka T, Imanishi M, Kaku K, Iwamoto Y, Kawamori R, Kikkawa R, Nakamura Y, Maeda S. Diabetologia. 2005 Jul;48(7):1315-22. Epub 2005 Jun 4. 2005
  182. SNP and mutation analysis. Wang L, Luhm R, Lei M. Adv Exp Med Biol. 2007;593:105-16. 2007
  183. SNP genotyping with fluorescence polarization detection. Kwok PY. Hum Mutat. 2002 Apr;19(4):315-23. Review. 2002
  184. Special commentary: patient safety and the next generation of HPV DNA tests. Kinney W, Stoler MH, Castle PE. Am J Clin Pathol. 2010 Aug;134(2):193-9. doi: 10.1309/AJCPRI8XPQUEAA3K. 2010
  185. TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6. Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Müller J, Meitinger T, Schömig A, Kastrati A. Clin Chem Lab Med. 2005;43(2):167-72. 2005
  186. Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. Miyagawa M, Naito T, Nishio SY, Kamatani N, Usami S.                PLoS One. 2013 Aug 13;8(8):e71381. doi: 10.1371/journal.pone.0071381. eCollection 2013. 2013
  187. Targeted screening and validation of copy number variations. Ceulemans S, van der Ven K, Del-Favero J. Methods Mol Biol. 2012;838:311-28. doi: 10.1007/978-1-61779-507-7_15. 2012
  188. Technologies for individual genotyping: detection of genetic polymorphisms in drug targets and disease genes. Shi MM. Am J Pharmacogenomics. 2002;2(3):197-205. Review. 2002
  189. The CAREGENE study: polymorphisms of the beta1-adrenoceptor gene and aerobic power in coronary artery disease. Defoor J, Martens K, Zielinska D, Matthijs G, Van Nerum H, Schepers D, Fagard R, Vanhees L. Eur Heart J. 2006 Apr;27(7):808-16. Epub 2006 Jan 18.  2006
  190. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection. Harvey M, Stout S, Starkey CR, Hendren R, Holt S, Miller GC. J Clin Virol. 2009 Jul;45 Suppl 1:S79-83. doi: 10.1016/S1386-6532(09)70012-5. 2009
  191. The evaluation of bacterial flora in progress of peri-implant disease. Sato J, Gomi K, Makino T, Kawasaki F, Yashima A, Ozawa T, Maeda N, Arai T. Aust Dent J. 2011 Jun;56(2):201-6. doi: 10.1111/j.1834-7819.2011.01324.x. 2011
  192. The International HapMap Project. The International HapMap Consortium. Nature 426, 789-796. 2003 2003
  193. The kinetics of oligonucleotide replacements. Reynaldo LP, Vologodskii AV, Neri BP, Lyamichev VI. J Mol Biol. 2000 Mar 24;297(2):511-20. 2000
  194. The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing. Naoki K, Soejima K, Okamoto H, Hamamoto J, Hida N, Nakachi I, Yasuda H, Nakayama S, Yoda S, Satomi R, Ikemura S, Terai H, Sato T, Watanabe K. Int J Clin Oncol. 2011 Aug;16(4):335-44. doi: 10.1007/s10147-011-0187-5. Epub 2011 Feb 11.  2011
  195. The present condition and a view of the food inspection using the invader method Hanazawa R, Yamaguchi T. Shokuhin Eiseigaku Zasshi. 2005 Feb;46(1):J1-3. 2005
  196. The responsible genes in Japanese deafness patients and clinical application using Invader assay. Usami S, Wagatsuma M, Fukuoka H, Suzuki H, Tsukada K, Nishio S, Takumi Y, Abe S. Acta Otolaryngol. 2008 Apr;128(4):446-54. doi: 10.1080/00016480701785046. 2008
  197. The rs8099917 polymorphism, when determined by a suitable genotyping method, is a better predictor for response to pegylated alpha interferon/ribavirin therapy in Japanese patients than other single nucleotide polymorphisms associated with interleukin-28B. Ito K, Higami K, Masaki N, Sugiyama M, Mukaide M, Saito H, Aoki Y, Sato Y, Imamura M, Murata K, Nomura H, Hige S, Adachi H, Hino K, Yatsuhashi H, Orito E, Kani S, Tanaka Y, Mizokami M. J Clin Microbiol. 2011 May;49(5):1853-60. doi: 10.1128/JCM.02139-10. Epub 2011 Mar 9. 2011
  198. Triage of Women With Negative Cytology and Positive High-Risk HPV: An Analysis of Data From the SHENCCAST II/III Studies. Goodrich SK, Pretorius RG, Du H, Wu R, Belinson JL. J Low Genit Tract Dis. 2013 Nov 21. [Epub ahead of print] 2013
  199. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay. Nagano M, Yamashita S, Hirano K, Ito M, Maruyama T, Ishihara M, Sagehashi Y, Oka T, Kujiraoka T, Hattori H, Nakajima N, Egashira T, Kondo M, Sakai N, Matsuzawa Y. J Lipid Res. 2002 Jul;43(7):1011-8. 2002
  200. Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results. Galan-Sanchez F, Rodriguez-Iglesias MA. APMIS. 2010 Sep 1;118(9):681-4. doi: 10.1111/j.1600-0463.2010.02639.x. 2010
  201. Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms. Langley MR, Booker JK, Evans JP, McLeod HL, Weck KE. J Mol Diagn. 2009 May;11(3):216-25. doi: 10.2353/jmoldx.2009.080123. Epub 2009 Mar 26. 2009
  202. Warfarin genotyping using three different platforms. Lefferts JA, Schwab MC, Dandamudi UB, Lee HK, Lewis LD, Tsongalis GJ. Am J Transl Res. 2010 Jul 25;2(4):441-6. 2010

All Resources